United States

S. 3794

SAFE Drugs Act of 2026

Health, Education, Labor, and Pensions Committee · Sen. Jim Banks (R-IN)

The bill would increase oversight of pharmacies that mix customized medications by allowing them to compound drugs that are essentially copies of commercially available products up to 20 times per month (compared to the current limit of 4 times per month) and would require certain large-scale compounding facilities and out-of-state operations to undergo regular inspections and submit annual reports to federal regulators.[AI-Generated]

Reported by committee 27 July 2026

Record as of 27 July 2026 — the most recent action in the official record. Status can lag; each step below carries its own date.

27 July 2026 Reported by committee
What's next: Floor scheduling (leadership decides if and when it gets a vote)
27 July 2026 Placed on calendar (Senate)
1 more action
1. 22 July 2026 Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
5 February 2026 Referred to committee
5 February 2026 Introduced in Senate

This path starts where the bill does — its first action in the official record. Routine procedural steps sit in the “more actions” rows above rather than on the main line.

Read the live feed — on the site or in the app Look up S. 3794 on Congress.gov All US bills